Ingmar Bruns

Insider Reports History

Location
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga, Ontario, Canada
Signature
/s/ Andrea Paul, attorney-in-fact for Ingmar Bruns
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ingmar Bruns:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Medical Officer Common Stock 36.6K $83.6K $2.28 Feb 6, 2025 Direct
Zentalis Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 16.6K Feb 3, 2025 Direct
Trillium Therapeutics Inc. Chief Medical Officer Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Ingmar Bruns

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZNTL Zentalis Pharmaceuticals, Inc. Feb 6, 2025 1 $45.7K 4 Feb 12, 2025 Chief Medical Officer
ZNTL Zentalis Pharmaceuticals, Inc. Feb 3, 2025 2 $0 4 Feb 5, 2025 Chief Medical Officer
ZNTL Zentalis Pharmaceuticals, Inc. Dec 2, 2024 1 $0 4 Dec 3, 2024 Chief Medical Officer
ZNTL Zentalis Pharmaceuticals, Inc. Nov 13, 2024 0 $0 3 Nov 13, 2024 Chief Medical Officer
TRIL Trillium Therapeutics Inc. Nov 17, 2021 1 $0 4 Nov 19, 2021 Chief Medical Officer